API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. G 137
2. G-137
1. 32828-81-2
2. 4-methoxy-n,n'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide
3. 4-methoxy-1-n,3-n-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide
4. G-137
5. Nsc-304384
6. 654g2vci4q
7. Einecs 251-245-7
8. Picotamide [inn:ban]
9. Brn 0499268
10. Unii-654g2vci4q
11. 4-methoxy-n,n'-bis(3-pyridylmethyl)isophthaldiamide
12. Sr-01000076086
13. G 137
14. N,n'-bis(3-picolyl)-4-methoxyisophthalamide
15. Plactidil (tn)
16. 4-methoxy-n,n'-bis(3-pyridylmethyl)isophthalamide
17. Picotamide (ban)
18. Isophthalamide, 4-methoxy-n,n'-bis(3-pyridylmethyl)-
19. Picotamide [mi]
20. N,n'-bis(3-pyridinylmethyl)-4-methoxy-1,3-benzenedicarboxamide
21. Prestwick0_000119
22. Prestwick1_000119
23. Prestwick2_000119
24. Prestwick3_000119
25. Lopac-p-8477
26. Picotamide [mart.]
27. Picotamide [who-dd]
28. Lopac0_001003
29. Bspbio_000138
30. N,n'-bis(3-pyridylmethyl)-4-methoxyisophthalamide
31. Schembl137025
32. Spbio_002077
33. Bpbio1_000152
34. Chembl1257015
35. Chebi:93175
36. Gtpl11379
37. Dtxsid40186498
38. Hms2090l18
39. Hms3263i07
40. Zinc538174
41. Tox21_501003
42. 1,3-benzenedicarboxamide, N,n'-bis(3-pyridinylmethyl)-4-methoxy-
43. Bdbm50103507
44. Nsc304384
45. Ccg-205083
46. Db13327
47. Lp01003
48. Nsc 304384
49. Sdccgsbi-0050976.p003
50. (s)-(-)-2-methoxypropionicacid
51. Ncgc00015847-01
52. Ncgc00015847-02
53. Ncgc00015847-03
54. Ncgc00015847-04
55. Ncgc00015847-05
56. Ncgc00094297-01
57. Ncgc00094297-02
58. Ncgc00261688-01
59. Sbi-0050976.p002
60. Db-048275
61. Eu-0101003
62. Ft-0630565
63. D07140
64. P 8477
65. 828p812
66. L013375
67. J-018896
68. Q1235921
69. Sr-01000076086-1
70. 4-methoxy-n1,n3-bis(pyridin-3-ylmethyl)isophthalamide
71. Brd-k67277431-002-03-0
72. 1,3-benzenedicarboxamide, 4-methoxy-n,n'-bis(3-pyridinylmethyl)-
73. 4-methoxy-n1,n3-bis(3-pyridinylmethyl)benzene-1,3-dicarboxamide
74. 1,3-benzenedicarboxamide, 4-methoxy-n1,n3-bis(3-pyridinylmethyl)-
75. 1085306-93-9
Molecular Weight | 376.4 g/mol |
---|---|
Molecular Formula | C21H20N4O3 |
XLogP3 | 1.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 376.15354051 g/mol |
Monoisotopic Mass | 376.15354051 g/mol |
Topological Polar Surface Area | 93.2 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 516 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
B - Blood and blood forming organs
B01 - Antithrombotic agents
B01A - Antithrombotic agents
B01AC - Platelet aggregation inhibitors excl. heparin
B01AC03 - Picotamide